MedTrace Logo

Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome

NCT00565903 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1247

Last updated 2023-03-01

No results posted yet for this study

Summary

Pleuropulmonary Blastoma (PPB) is a rare lung tumor which develops in childhood. The underlying genetic factors which contribute to the development and progression of PPB are not defined. We are working to identify the genetic factors which may contribute to the development of this rare tumor.

Conditions

  • Pleuropulmonary Blastoma
  • Cystic Nephroma
  • Sertoli-Leydig Cell Tumor of Ovary
  • Medulloepithelioma
  • Embryonal Rhabdomyosarcoma of Cervix
  • Goiter
  • Sarcoma
  • Pineoblastoma
  • Pituitary Tumors
  • Wilms Tumor

Sponsors & Collaborators

  • Ashley Hill

    lead OTHER

Principal Investigators

  • D. Ashley Hill, MD · Children's National Research Institute

  • Kris Ann Schultz, MD · Children's Hospital and Clinics of Minnesota

Eligibility

Min Age
1 Day
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2018-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00565903 on ClinicalTrials.gov